gelEye Health Secures $9M to Revolutionize NICU Care with AI
December 15, 2025, 3:38 pm
Location: United States, North Carolina, Wilmington
Employees: 501-1000
Founded date: 2008
AngelEye Health just raised $9 million in Series C funding. This investment fuels the launch of AIVision. AIVision is an AI-powered monitoring system for Neonatal Intensive Care Units (NICUs). AngelEye already serves over 350 hospitals. They reach 20% of U.S. NICU families. The company shifts focus from family engagement to proactive clinical insights. Nationwide Children’s Hospital joined the funding round. This validates AngelEye’s clinical value. AIVision uses existing camera feeds. It identifies risks and improves patient monitoring. AngelEye’s evolution mirrors a broader trend. Medtech companies are becoming data platforms. This funding will enhance patient safety and streamline workflows. It also strengthens family connections within the NICU. The company’s success is marked by rapid growth and industry recognition. AngelEye is poised to redefine the “smart NICU” landscape. This article details the funding, strategy shift, and potential impact of AIVision on neonatal and pediatric care. It explores the significance of Nationwide Children’s Hospital’s investment. It also highlights AngelEye’s broader trajectory in the evolving medtech sector. The article is optimized for search terms like "NICU technology," "AI in healthcare," "neonatal care," "AngelEye Health," and "smart hospital."
---
AngelEye Health secured $9 million. Series C funding will drive innovation. The Nashville-based company focuses on NICUs. They are expanding into pediatric care.
The funding round was led by Mountain Group Partners. Nationwide Children’s Hospital also invested. Live Oak Bank provided a debt facility. This capital supports AIVision’s launch. AIVision is an AI-driven monitoring tool.
AngelEye initially focused on family livestreaming. Now, they prioritize clinical intelligence. This represents a strategic shift. They are moving beyond engagement tools. They are building a comprehensive data platform.
Nationwide Children’s Hospital’s investment is key. It validates AngelEye’s clinical utility. Luke Brown joins AngelEye’s board. He is VP of Finance at Nationwide Children’s.
AIVision analyzes existing video feeds. It uses computer vision and machine learning. The goal is proactive risk identification. It provides earlier insights into patient status. This enhances care team capabilities.
AngelEye serves over 350 hospitals. They reach 20% of U.S. NICU families. Their existing tools include CameraSystem and MilkTracker. AIVision upgrades existing infrastructure. No major hardware overhaul is needed.
This funding accelerates AIVision’s deployment. It strengthens AngelEye’s commercial reach. The company aims to build connected care environments. This includes neonatal and pediatric units.
AngelEye’s growth is impressive. They’ve appeared on the Inc. 5000 list four times. They are an Inc. Power Partner. They achieved SOC II Type 2 certification.
The company streamlines workflows. It boosts clinical efficiency. It strengthens family engagement. AIVision deepens their role in patient safety. It also improves operational performance.
AngelEye is evolving. They are transitioning from hardware to a data platform. This is a common trend in medtech. It allows for scalable innovation.
The investment signals confidence. It highlights the need for improved NICU support. It also emphasizes the importance of family connection. AngelEye is poised for continued growth. They are redefining the future of neonatal and pediatric care.
---
AngelEye Health secured $9 million. Series C funding will drive innovation. The Nashville-based company focuses on NICUs. They are expanding into pediatric care.
The funding round was led by Mountain Group Partners. Nationwide Children’s Hospital also invested. Live Oak Bank provided a debt facility. This capital supports AIVision’s launch. AIVision is an AI-driven monitoring tool.
AngelEye initially focused on family livestreaming. Now, they prioritize clinical intelligence. This represents a strategic shift. They are moving beyond engagement tools. They are building a comprehensive data platform.
Nationwide Children’s Hospital’s investment is key. It validates AngelEye’s clinical utility. Luke Brown joins AngelEye’s board. He is VP of Finance at Nationwide Children’s.
AIVision analyzes existing video feeds. It uses computer vision and machine learning. The goal is proactive risk identification. It provides earlier insights into patient status. This enhances care team capabilities.
AngelEye serves over 350 hospitals. They reach 20% of U.S. NICU families. Their existing tools include CameraSystem and MilkTracker. AIVision upgrades existing infrastructure. No major hardware overhaul is needed.
This funding accelerates AIVision’s deployment. It strengthens AngelEye’s commercial reach. The company aims to build connected care environments. This includes neonatal and pediatric units.
AngelEye’s growth is impressive. They’ve appeared on the Inc. 5000 list four times. They are an Inc. Power Partner. They achieved SOC II Type 2 certification.
The company streamlines workflows. It boosts clinical efficiency. It strengthens family engagement. AIVision deepens their role in patient safety. It also improves operational performance.
AngelEye is evolving. They are transitioning from hardware to a data platform. This is a common trend in medtech. It allows for scalable innovation.
The investment signals confidence. It highlights the need for improved NICU support. It also emphasizes the importance of family connection. AngelEye is poised for continued growth. They are redefining the future of neonatal and pediatric care.